Acute Respiratory Distress Syndrome (ARDS) is a severe inflammatory lung condition and one of the most challenging syndromes encountered in critical care. Yet despite decades of research, treatment remains largely non-specific.
As our understanding of its underlying biology evolves, a fundamental question emerges: should ARDS continue to be approached as a single clinical entity given the profound biological heterogeneity of patients?
In this publication, we explore why patient stratification and precision medicine could play a pivotal role in shaping the future of ARDS management.
We invite you to discover our perspective👇
